HIV Resistance-Testing Information on Web
Blood tests now coming into use can provide some information about which anti-HIV drugs are unlikely to work for a particular patient, because their virus has become resistant to those drugs. Updated HIV-treatment guidelines now, for the first time, recommend such resistance testing in some cases (see "New Guidelines for HIV Treatment; Resistance Testing Now Recommended," in this issue).A Web site for physicians provides brief articles on resistance testing, ask-the-experts questions and answers, tables showing which mutations affect which drugs, a glossary, and other background information. "Designed to deliver important new research findings to the practicing clinician, each feature article contains pertinent background information and an emphasis on practical implications." Next month a review of drug-resistance information from the recent Retroviruses conference will be added.
Article topics include new drugs in development, changing FDA requirements for approval of new resistance tests and of new drugs, and reports from the 3rd International Workshop on HIV Drug Resistance, San Diego, 1999. See especially the "Best of Site" page.
This site is funded through the UCLA Clinical AIDS Research and Education (CARE) Center, and is made possible by an unrestricted educational grant from Roche Pharmaceuticals. It is available at: (website no longer available).
